batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. ASH 2023 – Incyte hopes to add axatilimab to the arsenal 10 December 2023 ASH 2023 – Novartis sees early TIM-3 promise 9 December 2023 ASH 2023 – Bristol follows in Talvey’s slipstream 9 December 2023 Sanofi’s Sarclisa gets one up on Darzalex 8 December 2023 ESMO-IO 2023 – Coherus’s combo strategy takes shape 6 December 2023 Syros gets a "win" at last 6 December 2023 Replimune marks another oncolytic virus failure 5 December 2023 Merck KGaA buys into a race with Deciphera 4 December 2023 Load More